Urinary Tract Malignancies
Conditions
Interventions
None listed
Sponsors
Fukushima Medical University
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: (1) Patients must be 18 years of age or older at the time of initial diagnosis. 2) Patients diagnosed with urologic malignancy based on imaging and pathological diagnosis between October 2008 and October 2028, and undergoing surgical therapy or drug therapy. (iii) Patients suspected of the presence of urologic malignancy based on diagnostic imaging.
Exclusion criteria
Exclusion criteria: (1) Patients with other active malignancies (during treatment or within 3 years after treatment) 2) Patients with other comorbidities that make surgical therapy, drug therapy, or histological examination difficult. (iii) Patients for whom normal follow-up, including imaging tests, is impossible due to other comorbidities or other reasons. (iv) Other patients deemed inappropriate by the principal investigator or subinvestigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-free survival for each urinary malignancy | — |
Countries
Japan
Contacts
Public Contactseiji hoshi
Fukushima Medical University Urology
Outcome results
None listed